EQT Life Sciences 8-Core Cooperatief U.A.
New Filing
CIK: 0002096488·Pooled Investment Fund·NETHERLANDS·Filed: Apr 28, 2026
Total Offering
Indefinite
Amount Sold
$0
Investors
0
First Sale
N/A
Offering Details
- Type
- Equity, Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(1), Section 3(c)(7)
- Entity Type
- Other
- Year Incorporated
- 2025
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Cillian Robert King | |
| Philippus Scheltens | |
| Felice Isabel Verduyn-van Weegen | |
| Rene Robert Kuijten | |
| N/A EQT Life Sciences 8 Director B.V. |
Company
SEC Filing
0002096488-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free